Form 4: ICU Medical Director David C. Greenberg Reports Stock Transactions

Director David C. Greenberg reports the acquisition and disposal of ICU Medical Inc. stock and derivative securities.

Summary

• On May 13, 2025, David C. Greenberg, a director of ICU Medical Inc., reported transactions involving the company's stock.
• Greenberg acquired 1,723 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.00.
• He also acquired 1,942 shares of common stock through the exercise of non-qualified stock options at a price of $94.68.
• Concurrently, Greenberg disposed of 1,942 shares of common stock at a price of $143.6624.
• Following these transactions, Greenberg directly owns 6,760 shares of common stock and indirectly owns 500 shares through a trust.
• He also holds 1,254 derivative securities in the form of unvested RSUs.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions. There is no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company leadership.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly diluting the stock.

Key Dates

Keywords

ICU Medical Inc., David C. Greenberg, stock transactions, Form 4, director, restricted stock units, non-qualified stock options, beneficial ownership